AlphaImpactRx, Inc., headquartered in the United States, is a leading player in the healthcare technology industry, specialising in innovative solutions for pharmaceutical and biotechnology companies. Founded in 2015, the company has rapidly established itself as a trusted partner in the realm of data analytics and market access strategies, with a focus on enhancing patient outcomes and optimising drug commercialisation. With a robust portfolio of services, including real-world evidence generation and market intelligence, AlphaImpactRx distinguishes itself through its commitment to data-driven insights and tailored solutions. The company has achieved significant milestones, including partnerships with major industry stakeholders, solidifying its position as a key contributor to the evolving landscape of healthcare analytics. As it continues to expand its operational reach, AlphaImpactRx remains dedicated to driving impactful change within the pharmaceutical sector.
How does AlphaImpactRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AlphaImpactRx, Inc.'s score of 23 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AlphaImpactRx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures. Consequently, there are no recorded emissions across Scope 1, Scope 2, or Scope 3. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. In the context of the industry, it is essential for companies to adopt robust climate strategies and set measurable targets to mitigate their environmental impact. As AlphaImpactRx, Inc. moves forward, establishing clear climate commitments and reduction initiatives will be crucial for aligning with global sustainability goals and enhancing their corporate responsibility profile.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AlphaImpactRx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.